AXA supports UNICEF’s efforts to roll out COVID-19 vaccines worldwide
May 12 2021
PARIS, 12 May 2021 – AXA, a global insurance company, has donated 1.5 million Euros to UNICEF’s work to ensure equal access to COVID-19 vaccines around the world.
The funding will support UNICEF’s work as the lead delivery and procurement partner of the COVAX Facility, the global vaccine alliance that aims to accelerate the development and manufacture of COVID-19 vaccines, and to guarantee fair and equitable access to COVID-19 vaccines for all countries globally. COVAX is the vaccines pillar of the global Access to COVID-19 Tools Accelerator (ACT-A).
The COVAX Facility has called upon UNICEF to procure and help deliver more than 2 billion COVID-19 vaccines for 92 low- and middle-income countries by the end of 2021. The initiative will be the largest vaccine procurement and supply operation ever.
AXA’s funding will support multiple activities carried out by UNICEF to deliver vaccines in low- and middle-income countries. This includes planning and coordination, vaccine transport in countries, training health staff, community engagement and providing health workers with personal protective equipment.
By focusing on priority groups, including those most at risk as well as health workers, teachers and social workers, UNICEF’s support to COVAX and ACT-A aims to save lives, help economies restart, and allow children and their families to access the health, education and protection services they need to help get their lives back to normal again.
The donation is in addition to AXA’s support for UNICEF’s programmes on the prevention of childhood obesity and overweight in Brazil and the Philippines, which began in 2019.
For media enquiries, please contact:
Sohini Roychowdhury, Communication Specialist
Tel: +41 79433 5264
UNICEF works in some of the world’s toughest places, to reach the world’s most disadvantaged children. Across 190 countries and territories, we work for every child, everywhere, to build a better world for everyone. For more information about UNICEF and its work for children, visit www.unicef.org. Follow us on Twitter and Facebook.
UNICEF does not endorse any company, brand, product or service.
About the COVAX Facility
COVAX, the vaccines pillar of the Access to COVID-19 Tools (ACT) Accelerator, is co-led by the Coalition for Epidemic Preparedness Innovations (CEPI), Gavi, the Vaccine Alliance Gavi) and the World Health Organization (WHO) – working in partnership with developed and developing country vaccine manufacturers, UNICEF, the World Bank, and others. It is the only global initiative that is working with governments and manufacturers to ensure COVID-19 vaccines are available worldwide to both higher-income and lower-income countries.
The AXA Group is a worldwide leader in insurance and asset management, with 153,000 employees serving 105 million clients in 54 countries. In 2020, IFRS revenues amounted to Euro 96.7 billion and underlying earnings to Euro 4.3 billion. AXA had Euro 1,032 billion in assets under management as of December 31, 2020. The AXA ordinary share is listed on compartment A of Euronext Paris under the ticker symbol CS (ISN FR 0000120628 – Bloomberg: CS FP – Reuters: AXAF.PA). AXA’s American Depository Share is also quoted on the OTC QX platform under the ticker symbol AXAHY. The AXA Group is included in the main international SRI indexes, such as Dow Jones Sustainability Index (DJSI) and FTSE4GOOD. It is a founding member of the UN Environment Programme’s Finance Initiative (UNEP FI) Principles for Sustainable Insurance and a signatory of the UN Principles for Responsible Investment.